Sign up to save your podcasts
Or
Share HMP CME (Audio)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HMP CME (Audio)
By Imedex
HMP CME serves as a powerful, year-round medical education resource featuring both in person and online offerings.... more
FAQs about HMP CME (Audio):
How many episodes does HMP CME (Audio) have?
The podcast currently has 1,508 episodes available.
HMP CME (Audio) episodes:
September 29, 2015Jason R. Gotlib, MD, MS: Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - Yes 
September 29, 2015Raajit K. Rampal, MD, PhD: Evolution of the assessment of clinical benefit in polycythemia vera September 29, 2015Srdan Verstovsek, MD, PhD and Jason R. Gotlib, MD, MS: JAK Inhibitors for the Successful Management of Patients with Polycythemia Vera Expert Perspectives: JAK Inhibitors for the Successful Management of Patients with Polycythemia Vera...moreSeptember 29, 2015Srdan Verstovsek, MD, PhD, Elizabeth O. Hexner, MD, MSTR, and Guillermo Garcio-Manero, MD: MPN and MDS Expert Perspectives: 2015 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes...moreSeptember 28, 2015Srdan Verstovsek, MD, PhD: Development of Long-acting Interferon as New Therapy for PV and ET September 28, 2015Elizabeth O. Hexner, MD, MSTR: Long-acting Interferon: What is the Difference? September 28, 2015Ruben A. Mesa, MD: Indication for Cytoreductive Therapy in ET and PV: Do We Have It Right? September 07, 2015Srdan Verstovsek, MD, PhD: Hydroxyurea intolerance/resistance in PV: Definition, clinical implications, and new therapy September 07, 2015Olatoyosi Odenike, MD: Why is hydroxyurea first line therapy in the US for ET, and not anagrelide or interferon? September 07, 2015Elizabeth Hexner, MD, MSTR: "Masked" PV and PV "in evolution"
FAQs about HMP CME (Audio):
How many episodes does HMP CME (Audio) have?
The podcast currently has 1,508 episodes available.